Perioperative Atezolizumab Plus Fluorouracil, Leucovorin, Oxaliplatin, and Docetaxel for Resectable Esophagogastric Cancer: Interim Results From the Randomized, Multicenter, Phase II/III DANTE/IKF-s633 TrialSylvie Lorenzen, Matthias Biebl, Nils Homann et al.|Journal of Clinical Oncology|2023Cited by 192
NGS-Guided Precision Oncology in Breast Cancer and Gynecological Tumors—A Retrospective Molecular Tumor Board AnalysisNiklas Gremke, Elisabeth Mack, Fiona R. Rodepeter et al.|Cancers|2024Cited by 12